The measure had little chance of consideration in the Senate, where it would need bipartisan support to move, but it ...

Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...

Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...

Paramagnetic rim lesions and other imaging biomarkers that show up on MRI allow patients to be diagnosed and treated much ...

What are called autoimmune diseases can affect just about every part of the body — even the brain — and tens of millions of people. While most common in women, these diseases can strike anyone, adults ...

Multiple sclerosis (MS) is a chronic autoimmune disease characterized by the disruption of nerve signals and various ...

WEDNESDAY, Dec. 17, 2025 (HealthDay News) — An over-the-counter supplement called lipoic acid might help slow the loss of ...

Clinicians and health system leaders met in Portland, Oregon, on October 21, 2025, to discuss the evolving options for treating Alzheimer disease and multiple sclerosis.

Kennedy Jr. says medical gender treatments for children are neither safe nor effective. The administration is seeking to end ...

There's a significant and rising threat to public and animal health and the environment in relation to antimicrobial ...

Tolebrutinib was one of three oral BTK inhibitors that Sanofi acquired as part of its $3.7 billion buyout of Principia ...